Fundamental Virology, 4th Edition; and Fields Virology, 4th Edition, Volumes I and II:Fundamental Virology, 4th Edition;Fields Virology, 4th Edition, Volumes I and II
- 期刊名称Clinical Infectious Diseases
- 作者Knipe, David M.; Howley, Peter M.; Griffin, Diane E.; Lamb, Robert A.; Martin, Malcolm A.; Roizman, Bernard; Straus, Stephen E.; Rubin, Donald H.
- 卷第34卷
- 期第7期
- 印刷ISSN1058-4838
- 电子ISSN1537-6591
- 文件大小50.17KB
- 发表时间2002-04
- DOI10.1086/339330
- 页码1029-1030
1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: Synthesis and molecular mechanism of actionRahul Ray; James R. Lambert · 2011
Induction of Senescence in Cancer Cells by a Novel Combination of Cucurbitacin B and Withanone: Molecular Mechanism and Therapeutic PotentialGarg, Sukant; Huifu, He; Kumari, Anjani; Sundar, Durai; Kaul, Sunil C; Wadhwa, Renu · The Journals of Gerontology: Series A · 2019
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatmentYoichi Ozawa; Kazutomi Kusano; Takashi Owa; Akira Yokoi; Makoto Asada; Kentaro Yoshimatsu · 2012
Platinum neurotoxicity pharmacogeneticsMcWhinney, S. R.; Goldberg, R. M.; McLeod, H. L. · Molecular Cancer Therapeutics · 2009
The Discovery of Lapatinib (GW572016)Rusnak, D.; Gilmer, T. M. · Molecular Cancer Therapeutics · 2011
Therapeutic value of glycosaminoglycans in cancerYip, G. W. · Molecular Cancer Therapeutics · 2006
The Patient Impact FactorMolecular Cancer Therapeutics · 2011
The role of neuropilins in cancerEllis, L. M. · Molecular Cancer Therapeutics · 2006
Curcumin sensitizes multiple myeloma to chemotherapyMolecular Cancer Therapeutics · 2009
Studies in target-based treatmentKurzrock, R. · Molecular Cancer Therapeutics · 2007
Aurora kinase inhibitorMolecular Cancer Therapeutics · 2006